#56: Beyond the Abstract: Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?

The death rate from cancer has steadily declined over the past 25 years; however, worldwide there were 9.6 million deaths in 2018, with lung cancer still number one among all cancer types. In the latest episode of “Beyond the Abstract,” a program that explores the “whys” behind an article in The Annals of Thoracic Surgery, Dr. Kemp H. Kernstine joins host Dr. Tom Varghese to discuss whether tumor FDG-PET avidity represents enhanced glycolytic metabolism in non-small cell lung cancer.

Read the related Annals article, "Does tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?"